Livance Revenue and Competitors

Sao Paulo, SP Brazil

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Livance's estimated annual revenue is currently $69.7M per year.(i)
  • Livance's estimated revenue per employee is $168,750

Employee Data

  • Livance has 413 Employees.(i)
  • Livance grew their employee count by 6% last year.

Livance's People

NameTitleEmail/Phone
1
VP EngineeringReveal Email/Phone
2
Growth Product ManagerReveal Email/Phone
3
Principal Product ManagerReveal Email/Phone
4
CoordenadoraReveal Email/Phone
5
Gerente de unidadeReveal Email/Phone
6
Gerente operacionalReveal Email/Phone
7
Coordenadora de UnidadeReveal Email/Phone
8
Coordenadora de UnidadeReveal Email/Phone
9
Engenheiro de softwareReveal Email/Phone
10
Inside SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2674.9M141535%N/AN/A
#2
$0.3M50%N/AN/A
#3
$4.1M386%N/AN/A
#4
$243.1M12862%N/AN/A
#5
$0.5M80%N/AN/A
#6
$16.1M119-2%N/AN/A
#7
$0.5M80%N/AN/A
#8
$3.6M33-3%N/AN/A
#9
$69.7M4136%N/AN/A
Add Company

What Is Livance?

Livance is a space as a service company created to reinvent the medical office, eliminating fixed costs, admin tasks, providing autonomy, flexibility and mobility for healthcare professionals who wishes to have a unique place to see and captivate their patients.

keywords:N/A

N/A

Total Funding

413

Number of Employees

$69.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Livance News

2022-04-13 - Syrniki, tvarohové lívance tém?? bez mouky

Máte rádi tvaroh a milujete lívance? Pak byste m?li co nejd?ív vyzkoušet ukrajinské syrniki. Základ t?sta tvo?í spousta tvarohu, ale mouky...

2022-03-22 - Dejte do lívanc? perlivou vodu. Úpln? jednoduchý trik, který ...

Lívance si m?žete dop?át s ovocem, nebo bez, jen tak se sirupem. Zdroj: Shutterstock.com / Anna_Pustynnikova. 14. 03. 2022 | Doba ?tení 3 minuty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$65M4168%N/A
#2
$70.7M419-9%N/A
#3
$15M4315%N/A
#4
N/A4315%N/A
#5
$39.2M433N/AN/A